Mitochondrial encephalomyopathies-Fifty years on

Neurology

Volumn 81, Issue 3, 2013, Pages 281-291

  DiMauro, Salvatore ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CARDIOLIPIN; CELL NUCLEUS DNA; CYTOCHROME C OXIDASE; DYNAMIN II; DYNAMIN RELATED GUANOSINE TRIPHOSPHATASE; DYNAMIN RELATED PROTEIN 1; GANGLIOSIDE INDUCED DIFFERENTIATION PROTEIN 1; MITOCHONDRIAL DNA; MITOCHONDRIAL FISSION FACTOR; MITOFUSIN 2; PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RIBOSOME RNA; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; BARTH SYNDROME; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ENDOPLASMIC RETICULUM; ENDOSYMBIONT; EPIGENETICS; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRIAL RESPIRATION; NARP SYNDROME; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

HUMANS; MITOCHONDRIA; MITOCHONDRIAL ENCEPHALOMYOPATHIES;

EID: 84881295459     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31829bfe89     Document Type: Article

References (58)

1. Rowland LP. Molecular genetics, pseudogenetics, and clinical neurology. Neurology 1983;23:1179-1195
2. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B. a case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 1962;41:1776-1804
3. Holt IJ, Harding AE, Morgan Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717-719
4. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Lebers hereditary optic neuropathy. Science 1988;242:1427-1430
5. Sagan L. On the origin of mitosing cells. J Theor Biol 1967;14:255-274
6. Larsson NG, Holme B, Kristiansson B. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res 1990;28:131-136
7. McShane MA, Hammans SR, Sweeney M, et al. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 1991;48:39-42
8. Engel WK, Cunningham CG. Rapid examination of muscle tissue: an improved trichrome stain method for freshfrozen biopsy sections. Neurology 1963;13:919-923
9. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428-433
10. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T. G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992;50:852-858
11. DiMauro S, Andreu AL. Mutations in mtDNA: are we scraping the bottom of the barrel? Brain Pathol 2000;10:431-441
12. Schon EA, DiMauro S, Hirano KI. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet 2012;13:878-890
13. Payne BAJ, Wilson IJ, Yu-Wai-Man P, et al. Universal heteroplasmy of human mitochondrial DNA. Hum Mol Genet 2013;22:384-390
14. McFarland R, Clark KM, Morris AAM, et al. Multiple neonatal deaths due to homoplasmic mitochondrial DNA mutation. Nat Genet 2002;30:145-146
15. Horvath R, Kemp JP, Tuppen HAL, et al. Molecular basis of infantile reversible cytochrome c oxidase deficiency. Brain 2009;132:3165-3174
16. Chinnery PF, Elliott P, Hudson G, Samuels DC, Relton CL. Epigenetics, epidemiology and mitochondrial DNA diseases. Int J Epidemiol 2012;41:177-187
17. Giordano C, Montopoli M, Perli E, et al. Oestrogens ameliorate mitochondrial dysfunction in Lebers hereditary optic neuropathy. Brain 2011;134:220-234
18. Tanji K, Kunimatsu T, Vu TH, Bonilla E. Neuropathological features of mitochondrial disorders. Semin Cell Dev Biol 2001;12:429-439
19. Betts J, Jaros E, Perry RH, et al. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol 2006;32:359-373
20. Tay SHK, Nordli DR, Bonilla E, et al. Aortic rupture in mitochondrial encephalopathy, lactic acidosis, and strokelike episodes. Arch Neurol 2006;63:281-283
21. Hirano M, Ricci E, Koenigsberger MR, et al. MELAS: an original case and clinical criteria for diagnosis. Neuromuscul Disord 1992;2:125-135
22. Tachibana M, Sparman M, Sritanaudomchai H, et al. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 2009;461:367-372
23. Craven L, Elson JL, Irving L, et al. Mitochondrial DNA disease: new options for prevention. Hum Mol Genet 2011;20:R168-R174
24. Paull D, Emmanuele V, Weiss KA, et al. Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants. Nature 2013;493:632-637
25. Calvo S, Compton A, Hershman SG, et al. Molecular diagnosis of infantile mitochondrial disease with targeted nextgeneration sequencing. Sci Transl Med 2012;4:118ra110.
26. Ronchi D, Garone C, Bordoni A, et al. Next-generation sequencing discloses DGUOK mutations in adult patients with mtDNA multiple deletions. Brain 2012;135:3404-3415
27. Mayr JA, Haack TB, Graf E, et al. Lack of mitochondrial protein acylglycerol kinase causes Sengers syndrome. Am J Hum Genet 2012;90:314-320
28. Kornblum C, Nicholls T, Haack TB, et al. Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease. Nat Genet 2013;45:214-219
29. DiMauro S, Emmanuele V. The clinical spectrum of nuclear DNA-related mitochondrial disorders. In: Wong L-JC, ed. Mitochondrial Disorders Caused by Nuclear Genes. New York: Springer Science 1 Business Media; 2013:3-25
30. Spinazzola A, Zeviani M. Disorders of nuclear-mitochondrial intergenomic signaling. Gene 2005;354:162-168
31. Suomalainen A, Isohanni P. Mitochondrial DNA depletion syndromes: many genes, common mechanisms. Neuromuscul Disord 2010;20:429-437
32. Chrzanowska-Lightowlers ZMA, Horvath R, Lightowlers RN. 175th ENMC International Workshop: mitochondrial protein synthesis in health and disease, 25-27th June, 2010, Naarden, the Netherlands. Neuromuscul Disord 2011;21: 142-147
33. Christian BE, Spremulli LL. Mechanism of protein biosynthesis in mammalian mitochondria. Biochim Biophys Acta 2012;1819:1035-1054
34. Jacobs HT, Turnbull DM. Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet 2005;21:312-314
35. Smits P, Smeitink JAM, van den Heuvel B. Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies. J Biomed Biotechnol 2010;2010:737385.
36. Barth PG, Scholte HR, Berden JA, et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 1983;62:327-355
37. Schlame M, Ren M. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 2006;580:5450-5455
38. Claypool SM, Koehler CM. The complexity of cardiolipin in health and disease. Trends Biochem Sci 2012;37:32-41
39. Sengers RC, Stadhouders AM, van Lakwijk Vondrovicova E, Kubat K, Ruitenbeek W. Hypertrophic cardiomyopathy associated with a mitochondrial myopathy of voluntary muscles and congenital cataract. Br Heart J 1985;54:543-547
40. Sher RB, Aoyama C, Huebsch KA, et al. A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first enzyme in phosphatidylcholine biosynthesis. J Biol Chem 2006;281:4938-4948
41. Mitsuhashi S, Ohkuma A, Talim B, et al. A congenital muscular dystrophy with mitochondrial structural abnormalities caused by defective de novo phosphatidylcholine biosynthesis. Am J Hum Genet 2011;88:845-851
42. Gutierrez-Rios P, Kalra AA, Wilson JD, et al. Congenital megaconial myopathy due to a novel defect in the choline kinase beta (CHKB) gene. Arch Neurol 2012;69:657-661
43. Wortmann RL, Vaz FM, Gardeitchik T, et al. Mutation in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. Nat Genet 2012;44:797-802
44. Zeharia A, Shaag A, Houtkooper RH, et al. Mutations in LPIN cause recurrent childhood myoglobinuria in childhood. Am J Hum Genet 2008;83:489-494
45. Hayashi T, Rizzuto R, Hajnoczky G, Su TP. MAM: more than just a housekeeper? Trends Cell Biol 2009;19:81-88
46. Al-Saif A, Bohlega S, Al-Mohanna F. Loss of ERLIN2 function leads to juvenile primary lateral sclerosis. Ann Neurol 2012;72:510-516
47. Bellzil VV, Rouleau GA. Endoplasmic reticulum lipid rafts and upper motor neuron degeneration. Ann Neurol 2012; 72:479-480
48. Schon EA, Area Gomez E. Mitochondria-associated ER membranes in Alzheimer disease. Mol Cell Neurosci 2013;55:26-36
49. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006;125:1241-1252
50. Chen H, Chan DC. Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum Mol Genet 2009;18:R169-R176
51. Chan DC. Mitochondrial dynamics in disease. N Engl J Med 2007;356:1707-1709
52. Milone M, Benarroch EE. Mitochondrial dynamics: general concepts and clinical implications. Neurology 2012; 78:1612-1619
53. Amati-Bonneau P, Valentino ML, Reynier P, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy "plus" phenotypes. Brain 2008;131:338-351
54. Hudson G, amati-Bonneau P, Blakely E, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008;131:329-337
55. Rouzier C, Bannwarth S, Chaussenot A, et al. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy "plus" phenotype. Brain 2012;136:23-34
56. Vielhaber S Debska-Vielhaber G Peeva V et al Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion Acta Neuropathol 2013 125 245-256
57. Schon EA, Przedborski S. Mitochondria in the next (neurode) generation. Neuron 2011;70:1033-1053
58. Ropper AH. C. Miller Fisher (in memoriam). Ann Neurol 2012;72:1-3.